Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Gabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder.
Journal: Pharmacology, biochemistry, and behavior
Published: May 11, 2022
The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine's effects.
Journal: Behavioural pharmacology
Published: April 19, 2022
Minocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users.
Journal: Pharmacology, biochemistry, and behavior
Published: November 10, 2020
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.
Journal: Drug and alcohol dependence
Published: August 30, 2019
Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone.
Journal: Pharmacology, biochemistry, and behavior
Published: March 11, 2019
The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety.
Journal: Journal of psychoactive drugs
Published: September 12, 2018
Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential.
Journal: Pharmacology, biochemistry, and behavior
Published: June 23, 2017
Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount.
Journal: Drug and alcohol dependence
Published: November 21, 2016
Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: November 14, 2016
The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.
Journal: Physiology & behavior
Published: July 20, 2015
Baseline characteristics of patients predicting suitability for rapid naltrexone induction.
Journal: The American journal on addictions
Published: April 23, 2014
Last Updated: 09/26/2026